Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Predictive and prognostic potential of volume-based metabolic variables obtained...
Journal Information
Vol. 37. Issue 2.
Pages 73-79 (March - April 2018)
Share
Share
Download PDF
More article options
Visits
5
Vol. 37. Issue 2.
Pages 73-79 (March - April 2018)
Original Article
Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline 18F-FDG PET/CT in breast cancer with neoadjuvant chemotherapy indication
Papel predictivo y pronóstico de las variables volumétricas metabólicas obtenidas en la 18F-FDG PET/TC en cáncer de mama con indicación de quimioterapia adyuvante
Visits
5
A.M. Garcia-Vicentea,1,
Corresponding author
angarvice@yahoo.es

Corresponding author.
, J. Pérez-Betetab,1, M. Amo-Salasc,1, D. Molinab,1, G.A. Jimenez-Londoñoa,1, A.M. Soriano-Castrejóna,1, F.J. Pena Pardoa,1, A. Martínez-Gonzálezb,1
a Nuclear Medicine Department, Hospital General Universitario de Ciudad Real, Spain
b Instituto de Matemática Aplicada a la Ciencia y la Ingeniería, Universidad de Castilla-La Mancha, Ciudad Real, Spain
c Department of Mathematics, Universidad de Castilla-La Mancha, Ciudad Real, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (3)
Table 1. Patient's characteristics.
Table 2. Relation between SUV and volume-based variables with NC response and DFs.
Table 3. Results of ROC analysis of SUV and volume-based metabolic variables in the prediction of DFs and NC response (only significant associations are showed).
Show moreShow less
Abstract
Aim

To investigate the usefulness of metabolic variables using 18F-FDG PET/CT in the prediction of neoadjuvant chemotherapy (NC) response and the prognosis in locally advanced breast cancer (LABC).

Materials and methods

Prospective study including 67 patients with LABC, NC indication and a baseline 18F-FDG PET/CT. After breast tumor segmentation, SUV variables (SUVmax, SUVmean and SUVpeak) and volume-based variables, such as metabolic tumor volume (MTV) and total lesion glycolysis (TLG), were obtained. Tumors were grouped into molecular phenotypes, and classified as responders or non-responders after completion of NC. Disease-free status (DFs), disease-free survival (DFS), and overall survival (OS) were assessed. A univariate and multivariate analysis was performed to study the potential of all variables to predict DFs, DFS, and OS.

Results

Fourteen patients were classified as responders. Median±SD of DFS and OS was 43±15 and 46±13 months, respectively. SUV and TLG showed a significant correlation (p<0.005) with the histological response, with higher values in responders compared to non-responders. MTV and TLG showed a significant association with DFs (p=0.015 and p=0.038 respectively). Median, mean and SD of MTV and TLG for patients with DFs were: 8.90, 13.73, 15.10 and 33.78, and 90.54 and 144.64, respectively. Median, mean and SD of MTV and TLG for patients with non-DFs were: 16.72, 29.70 and 31.09 and 90.89, 210.98 and 382.80, respectively. No significant relationships were observed with SUV variables and DFs. Volume-based variables were significantly associated with OS and DFS, although in multivariate analysis only MTV was related to OS. No SUV variables showed an association with the prognosis.

Conclusion

Volume-based metabolic variables obtained with 18F-FDG PET/CT, unlike SUV based variables, were good predictors of both neoadjuvant chemotherapy response and prognosis.

Keywords:
18F-FDG PET/CT
Breast cancer
Volume-based metabolic variables
Prognosis
Neoadjuvant chemotherapy response
Resumen
Objetivo

Investigar la utilidad de las variables metabólicas obtenidas en la 18F-FDG PET/TC en la predicción de la respuesta a quimioterapia neoadyuvante (QN) y el pronóstico en cáncer de mama locamente avanzado (CMLA).

Material y métodos

Estudio prospectivo que incluye 67 pacientes con CMLA, indicación de QN y 18F-FDG PET/TC basal. Se obtuvieron variables SUV (SUVmax, SUVmedio y SUVpico) y volumétricas, tales como el volumen tumoral metabólico (VTM) y la glicólisis total lesional (GTL). Los tumores se agruparon en fenotipos moleculares y fueron clasificadas como respondedores y no respondedores tras la finalización de la QN. Se obtuvo el estado libre de enfermedad (ELE), supervivencia libre de enfermedad (SLE) y supervivencia global (SG). Se realizó análisis univariante y multivariante para estudiar el potencial de todas las variables en la predicción de la ELE, SLE y SG.

Resultados

Catorce pacientes se clasificaron como respondedoras. La media ±DE de la SLE y la SG fue de 43±15 y 46±13 meses, respectivamente. El SUV y la GTL mostraron una relación significativa (p<0,005) con la respuesta histológica, con mayores valores en las pacientes respondedoras con respecto a las no-respondedoras. El VTM y la GTL mostraron asociación con el ELE (p=0,015 y p=0,038, respectivamente). La mediana, media y DS del VTM y la GTL para pacientes en ELE fue de 8,90, 13,73, 15,10 y del 33,78, 90,54 y 144,64, respectivamente. La mediana, media y DS del VTM y la GTL para pacientes en no ELE fueron de: 16,72, 29,70 y 31,09 y de 90,89, 210,98 y 382,80, respectivamente. No se encontró relación con las variables de SUV y el ELE. Las variables volumétricas se asociaron de forma significativa con la SG y con la SLE, aunque en el análisis multivariante solo el VTM se relacionó con la SG. Ninguna variable de SUV mostró asociación con el pronóstico.

Conclusión

Las variables metabólicas obtenidas con la 18F-FDG PET/TC, de forma distinta a las variables de SUV, fueron buenos predictores tanto de la respuesta al tratamiento quimioterápico neoadyuvante y el pronóstico.

Palabras clave:
18F-FDG PET/TC
Cáncer de mama
Variables volumétricas metabólicas
Pronóstico
Respuesta a quimioterapia neoadyuvante

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos